The state of health in Belgium, 1990-2019: a benchmarking analysis based on the Global Burden of Disease 2019 study.
Burden of disease
Disability-Adjusted Life Years
Public health monitoring
Journal
Archives of public health = Archives belges de sante publique
ISSN: 0778-7367
Titre abrégé: Arch Public Health
Pays: England
ID NLM: 9208826
Informations de publication
Date de publication:
18 Oct 2022
18 Oct 2022
Historique:
received:
04
11
2021
accepted:
30
09
2022
entrez:
18
10
2022
pubmed:
19
10
2022
medline:
19
10
2022
Statut:
epublish
Résumé
In a context of decreasing resources and growing health needs, evidence-based health and care policies are essential. This study aims to assess the health trends in Belgium between 1990 and 2019, to compare the Belgian health status to that of the EU-15 countries, and to identify the main drivers in trends over time and country differences within the EU-15. We extracted estimates from the GBD 2019 study via the GBD results tool and visualization tools. We compared the Belgian health status with 14 European Union comparator countries between 1990 and 2019, and decomposed the time trends and country differences into the unique contributions of the different underlying causes of death and disability. Life expectancy (LE) in Belgium improved significantly between 1990 and 2019 for both men and women. Belgium age-standardised mortality rates dropped significantly for men (-40%) and women (-33%) between 1990 and 2019. Overall, Belgium age-standardised disability-adjusted life year (DALY) rates dropped by 23%. This decrease is mainly due to decreasing trends in age-standardised years of life lost (YLL) rates while age-standardised years lived with disability (YLD) rates remained stable. Compared to EU-15, Belgium's ranking in terms of age-standardised DALY rates worsened for both men and women in 2019. Self-harm and falls are major causes of disease burden, with DALY rates that are higher than in many other EU-15 countries, indicating a realistic potential for improvement. Lung cancer DALY rates remain worrisome for men, and even show an increasing trend for women. Increasing trends of headache disorders, drug use disorders, and diabetes, require further attention. Non-communicable diseases remain the main contributors for health burden in Belgium, with disability accounting for an increasingly larger share of the disease burden. Despite considerable improvements, Belgium's ranking for DALYs decreased between 1990 and 2019 compared to the EU-15. This study identified priority causes of disease burden based on their contributions to current evolutions and EU-15 differences. Since many of these causes are considered to be avoidable, primary and secondary prevention are crucial elements for reducing the burden of disease on the healthcare system.
Sections du résumé
BACKGROUND
BACKGROUND
In a context of decreasing resources and growing health needs, evidence-based health and care policies are essential. This study aims to assess the health trends in Belgium between 1990 and 2019, to compare the Belgian health status to that of the EU-15 countries, and to identify the main drivers in trends over time and country differences within the EU-15.
METHODS
METHODS
We extracted estimates from the GBD 2019 study via the GBD results tool and visualization tools. We compared the Belgian health status with 14 European Union comparator countries between 1990 and 2019, and decomposed the time trends and country differences into the unique contributions of the different underlying causes of death and disability.
RESULTS
RESULTS
Life expectancy (LE) in Belgium improved significantly between 1990 and 2019 for both men and women. Belgium age-standardised mortality rates dropped significantly for men (-40%) and women (-33%) between 1990 and 2019. Overall, Belgium age-standardised disability-adjusted life year (DALY) rates dropped by 23%. This decrease is mainly due to decreasing trends in age-standardised years of life lost (YLL) rates while age-standardised years lived with disability (YLD) rates remained stable. Compared to EU-15, Belgium's ranking in terms of age-standardised DALY rates worsened for both men and women in 2019. Self-harm and falls are major causes of disease burden, with DALY rates that are higher than in many other EU-15 countries, indicating a realistic potential for improvement. Lung cancer DALY rates remain worrisome for men, and even show an increasing trend for women. Increasing trends of headache disorders, drug use disorders, and diabetes, require further attention.
CONCLUSION
CONCLUSIONS
Non-communicable diseases remain the main contributors for health burden in Belgium, with disability accounting for an increasingly larger share of the disease burden. Despite considerable improvements, Belgium's ranking for DALYs decreased between 1990 and 2019 compared to the EU-15. This study identified priority causes of disease burden based on their contributions to current evolutions and EU-15 differences. Since many of these causes are considered to be avoidable, primary and secondary prevention are crucial elements for reducing the burden of disease on the healthcare system.
Identifiants
pubmed: 36258249
doi: 10.1186/s13690-022-00976-2
pii: 10.1186/s13690-022-00976-2
pmc: PMC9580164
doi:
Types de publication
Journal Article
Langues
eng
Pagination
222Informations de copyright
© 2022. The Author(s).
Références
BMC Public Health. 2018 Jun 20;18(1):775
pubmed: 29925365
Lancet. 2020 Oct 17;396(10258):1135-1159
pubmed: 33069324
Lancet. 2016 Dec 10;388(10062):e19-e23
pubmed: 27371184
Eur Heart J. 2014 Nov 7;35(42):2950-9
pubmed: 25139896
Arch Public Health. 2015 Jul 13;73(1):31
pubmed: 26171143
Lancet. 2018 Aug 18;392(10147):607-609
pubmed: 29661480
Cancer Epidemiol Biomarkers Prev. 2021 Jan;30(1):45-52
pubmed: 33082205
Health Syst Transit. 2020 Dec;22(5):1-237
pubmed: 33527904
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Can Geriatr J. 2013 Jun 03;16(2):61-5
pubmed: 23737931
BMC Public Health. 2014 Nov 21;14:1196
pubmed: 25416547
Arch Public Health. 2016 Jun 08;74:22
pubmed: 27280020
Acta Cardiol. 2014 Oct;69(5):473-81
pubmed: 25638834
Prev Med. 2014 Dec;69:280-6
pubmed: 25456812
BMC Public Health. 2017 Dec 16;17(1):958
pubmed: 29246218
Lancet. 2020 Oct 17;396(10258):1223-1249
pubmed: 33069327
Rev Neurol (Paris). 2015 Oct;171(10):707-14
pubmed: 26239062
Sante Ment Que. 2014 Spring;39(1):209-42
pubmed: 25120123
Science. 1996 Nov 1;274(5288):740-3
pubmed: 8966556
Health Aff (Millwood). 2013 Apr;32(4):686-94
pubmed: 23569048
Crit Care Nurs Q. 2011 Apr-Jun;34(2):154-8
pubmed: 21407011
Arch Public Health. 2014 Oct 01;72(1):34
pubmed: 25328677
Best Pract Res Clin Obstet Gynaecol. 2013 Oct;27(5):643-59
pubmed: 23541823
Radiology. 2011 Sep;260(3):658-63
pubmed: 21712474